| Aarey Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524412 |
NSE Symbol : AAREYDRUGS |
P/E(TTM) : 23.78 |
|
ISIN Demat : INE198H01019 |
Div & Yield% : - |
EPS(TTM) : 2.47 |
|
Book Value(₹) : 48.47 |
Market Cap(₹Cr) : 164.20 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 105.14 | 126.91 | 210.35 | 76.48 | 57.83 | 50.96 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 105.14 | 126.91 | 210.35 | 76.48 | 57.83 | 50.96 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.02 | 1.58 | 5.14 | 0.29 | 0.84 | 0.70 |
| Total Income | 105.16 | 128.49 | 215.49 | 76.77 | 58.67 | 51.65 |
| Total Expenditure | 101.42 | 125.73 | 211.79 | 73.77 | 55.98 | 49.62 |
| PBIDT | 3.74 | 2.75 | 3.70 | 3.00 | 2.68 | 2.04 |
| Interest | 0.49 | 0.47 | 0.40 | 0.47 | 0.41 | 0.42 |
| PBDT | 3.25 | 2.29 | 3.30 | 2.52 | 2.27 | 1.62 |
| Depreciation | 1.51 | 0.96 | 1.15 | 1.06 | 1.27 | 0.89 |
| Tax | 0.40 | 0.10 | 0.66 | -0.44 | -0.22 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.25 | -0.01 | -0.67 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 1.60 | 1.24 | 2.15 | 1.91 | 1.23 | 0.72 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.60 | 1.24 | 2.15 | 1.91 | 1.23 | 0.72 |
| EPS (Unit Curr.) | 0.57 | 0.44 | 0.77 | 0.75 | 0.48 | 0.29 |
| EPS (Adj) (Unit Curr.) | 0.57 | 0.44 | 0.77 | 0.75 | 0.48 | 0.29 |
| Calculated EPS (Unit Curr.) | 0.57 | 0.44 | 0.77 | 0.75 | 0.48 | 0.29 |
| Calculated EPS (Adj) (Unit Curr.) | 0.57 | 0.44 | 0.77 | 0.75 | 0.48 | 0.29 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.28 | 1.77 | 3.07 | 3.01 | 1.94 | 1.14 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.28 | 1.77 | 3.07 | 3.01 | 1.94 | 1.14 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 28.05 | 28.05 | 28.05 | 25.38 | 25.38 | 25.38 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 3.56 | 2.17 | 1.76 | 3.92 | 4.63 | 4.00 |
| PBDTM(%) | 3.09 | 1.80 | 1.57 | 3.29 | 3.93 | 3.18 |
| PATM(%) | 1.52 | 0.98 | 1.02 | 2.50 | 2.13 | 1.41 |